DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,724,882 | +6.6% | 10,983 | +3.1% | 0.06% | +13.5% |
| Q2 2023 | $2,556,480 | -34.2% | 10,652 | -30.9% | 0.05% | -34.2% |
| Q1 2023 | $3,882,928 | -14.8% | 15,406 | -10.3% | 0.08% | -16.0% |
| Q4 2022 | $4,556,200 | -28.4% | 17,166 | -30.4% | 0.09% | -29.9% |
| Q3 2022 | $6,367,000 | -16.5% | 24,651 | -18.1% | 0.13% | -7.6% |
| Q2 2022 | $7,629,000 | -20.7% | 30,091 | -8.3% | 0.14% | -2.0% |
| Q1 2022 | $9,626,000 | -16.9% | 32,816 | -6.7% | 0.15% | -10.3% |
| Q4 2021 | $11,577,000 | +4.1% | 35,188 | -3.7% | 0.16% | -2.4% |
| Q3 2021 | $11,122,000 | -19.7% | 36,534 | -29.2% | 0.17% | -17.2% |
| Q2 2021 | $13,852,000 | +8.3% | 51,618 | -9.1% | 0.20% | +2.5% |
| Q1 2021 | $12,787,000 | -12.6% | 56,812 | -13.7% | 0.20% | -17.8% |
| Q4 2020 | $14,623,000 | -4.6% | 65,827 | -7.6% | 0.24% | -14.8% |
| Q3 2020 | $15,334,000 | +16.2% | 71,212 | -4.6% | 0.28% | +10.5% |
| Q2 2020 | $13,197,000 | +29.1% | 74,632 | +1.1% | 0.26% | +5.8% |
| Q1 2020 | $10,220,000 | -1.9% | 73,838 | +8.8% | 0.24% | +32.8% |
| Q4 2019 | $10,417,000 | +11.7% | 67,875 | +5.1% | 0.18% | +6.4% |
| Q3 2019 | $9,324,000 | +9.2% | 64,558 | +8.0% | 0.17% | +11.7% |
| Q2 2019 | $8,540,000 | +34.9% | 59,752 | +24.6% | 0.15% | +36.3% |
| Q1 2019 | $6,331,000 | +53.2% | 47,953 | +19.6% | 0.11% | +36.1% |
| Q4 2018 | $4,133,000 | -2.5% | 40,082 | +2.8% | 0.08% | +20.3% |
| Q3 2018 | $4,238,000 | -7.6% | 39,000 | -16.1% | 0.07% | -11.5% |
| Q2 2018 | $4,588,000 | -24.3% | 46,494 | -24.9% | 0.08% | -22.8% |
| Q1 2018 | $6,057,000 | +3.9% | 61,947 | -1.4% | 0.10% | +5.2% |
| Q4 2017 | $5,829,000 | -1.8% | 62,804 | -9.3% | 0.10% | -3.0% |
| Q3 2017 | $5,938,000 | -13.3% | 69,221 | -14.7% | 0.10% | -13.2% |
| Q2 2017 | $6,846,000 | -1.8% | 81,129 | -0.4% | 0.11% | -2.6% |
| Q1 2017 | $6,969,000 | +17.5% | 81,481 | +6.9% | 0.12% | +19.4% |
| Q4 2016 | $5,932,000 | +14.2% | 76,210 | +15.0% | 0.10% | +15.3% |
| Q3 2016 | $5,193,000 | -23.4% | 66,241 | -1.3% | 0.08% | -22.7% |
| Q2 2016 | $6,781,000 | +15.9% | 67,134 | +8.8% | 0.11% | +13.4% |
| Q1 2016 | $5,851,000 | -6.6% | 61,678 | -8.5% | 0.10% | -2.0% |
| Q4 2015 | $6,264,000 | +15.2% | 67,438 | +5.7% | 0.10% | +13.8% |
| Q3 2015 | $5,436,000 | -4.5% | 63,801 | -4.1% | 0.09% | +11.5% |
| Q2 2015 | $5,691,000 | +0.2% | 66,496 | -0.6% | 0.08% | +2.6% |
| Q1 2015 | $5,681,000 | +6.4% | 66,918 | +7.5% | 0.08% | +5.6% |
| Q4 2014 | $5,337,000 | +28.9% | 62,269 | +14.3% | 0.07% | +26.3% |
| Q3 2014 | $4,139,000 | -9.5% | 54,472 | -6.2% | 0.06% | -9.5% |
| Q2 2014 | $4,574,000 | +16.5% | 58,095 | +11.0% | 0.06% | +5.0% |
| Q1 2014 | $3,926,000 | +21.3% | 52,348 | +24.9% | 0.06% | +15.4% |
| Q4 2013 | $3,236,000 | +66.6% | 41,912 | +49.6% | 0.05% | +52.9% |
| Q3 2013 | $1,942,000 | +10.5% | 28,018 | +0.9% | 0.03% | +3.0% |
| Q2 2013 | $1,758,000 | – | 27,769 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |